September 15, 2023
GlaxoSmithKline LLC, Johnson & Johnson Consumer Inc. and other drug companies reaped billions of dollars by selling ineffective over-the-counter nasal decongestants, according to a pair of proposed class actions filed in New Jersey federal court just two days after the U.S. government announced that a key ingredient in the remedies doesn't work.